NCT01010932

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Evaluation of Dotarem-enhanced MRA Compared to Time-Of-Flight (TOF) MRA in the Diagnosis of Carotid and Vertebral Basilar Arterial Disease

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 222 (actual)
• Sponsor: Guerbet · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The study will evaluate the efficacy and safety of Dotarem enhanced MRA in patients suffering from carotid or vertebral arterial disease.

Detailed description

Each subject will undergo a Time Of Flight (TOF) Magnetic Resonance Angiography (MRA) followed by a Dotarem enhanced MRA.

Conditions

• Cerebral Arterial Diseases

Interventions

Type	Name	Description
DRUG	Dotarem	Each subject will receive one injection of Dotarem 0.2ml/kg
OTHER	TOF MRA	Each subject will undergo a Time of Flight Magnetic Resonance Angiography (TOF MRA)

Timeline

• Start date: 2009-10-01
• Primary completion: 2010-12-01
• Completion: 2010-12-01
• First posted: 2009-11-10
• Last updated: 2016-06-16
• Results posted: 2015-08-25

Locations

1 site across 1 country: United States